Psyence Biomedical Ltd.
Healthcare / Biotechnology
Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is based in Toronto, Canada. Psyence Biomedical Ltd. is a subsidiary of Psyence Group Inc.
Performance
--
Today 0.00 (0.00%)
PBM
Metrics
Market Cap0
Latest Price$5.89
Previous Close$5.82
Volume23K
52 Week High$216.41
52 Week Low$1.92
52 Week Change-97.19%
Average Volume81K
Revenue0
EPS-12.56
P/E Ratio0
Forward P/E0
Price/Book0.797
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-0.59%
Dividend Yield0.00%